Advertisement
Advertisement
Health

Tuberculosis Killed 1.1 Million Globally In 2025 – WHO

Despite a decade of progress in the global fight against tuberculosis, the disease killed an estimated 1.1 million people worldwide in 2025, highlighting persistent gaps in diagnosis, treatment and access to healthcare, the World Health Organisation has said.

The WHO, in its 2026 Global Tuberculosis Report released on Thursday, said an estimated 10.6 million people developed the disease last year, making tuberculosis the leading cause of death from a single infectious agent globally.

Although TB-related deaths have declined by 35 per cent over the past decade, the organisation said the disease continued to claim more than one million lives annually, despite being both preventable and treatable.

The report noted that the reduction in mortality marked the achievement of the first mortality milestone of the WHO’s End TB Strategy, although the target was reached five years behind schedule.

It, however, expressed concern over the slow reduction in new infections, revealing that the global TB incidence rate fell by only 14 per cent between 2015 and 2025, significantly below the 50 per cent reduction target set for 2025.

WHO Director-General, Dr Tedros Adhanom Ghebreyesus, described the continued decline in infections and deaths as encouraging, particularly amid funding constraints confronting healthcare systems in several countries.

He said, “The continued decline in TB cases and deaths is very encouraging, especially given the challenges many countries have faced from funding cuts.”

Tedros, however, warned that the persistent death toll highlighted the urgent need to strengthen prevention, diagnosis and treatment services.

“Many governments have dug deeper into their own budgets to protect the gains they have made. And yet, more than one million people still die each year from a disease that is preventable and treatable.

“We urge countries and partners to urgently expand access to TB services, protect essential funding and accelerate the development of new tools to end this epidemic,” he added.

The WHO identified inadequate diagnosis and reporting as major obstacles to controlling the disease, noting that only 8.4 million of the estimated 10.6 million people who developed TB in 2025 were diagnosed.

This left approximately 2.2 million cases either undiagnosed or unreported, raising concerns about the number of infected people who may remain outside the healthcare system and continue to transmit the disease.

The organisation also disclosed that only 59 per cent of newly diagnosed patients were tested using WHO-recommended rapid diagnostic tests, falling short of its target of ensuring universal access to such testing by 2027.

According to the report, the global TB burden remained concentrated in 30 countries, which accounted for 88 per cent of all people who developed the disease in 2025.

A breakdown of regional performance showed that the WHO African Region recorded a 30 per cent reduction in TB incidence between 2015 and 2025, while Europe achieved a 42 per cent decline.

Advertisement
Advertisement

South-East Asia recorded an 18 per cent reduction, while the Eastern Mediterranean Region witnessed a 6.6 per cent decline.

However, the Americas recorded a 13 per cent increase in TB incidence compared with 2015, while the Western Pacific Region reported no net change.

Beyond the burden of ordinary TB infections, the WHO raised concerns over the growing challenge of drug-resistant tuberculosis, particularly rifampicin-resistant TB, which is more difficult and expensive to treat.

It estimated that 370,000 people developed rifampicin-resistant TB in 2025, but only 42 per cent received treatment.

The report, however, highlighted improvements in access to shorter treatment options, noting that the uptake of its recommended six-month treatment regimen among patients receiving care increased from 18 per cent in 2024 to 42 per cent in 2025.

On financing, the WHO said domestic investment in TB programmes rose by 14 per cent, reaching $5.6bn between 2024 and 2025.

The increase partly compensated for a decline in international funding of a similar scale, although the organisation warned that the overall financing situation remained inadequate.

Investment in research was particularly concerning, with funding standing at $1.2bn in 2023, less than one-quarter of the $5bn annual investment required by 2027.

The WHO called on governments, development partners and other stakeholders to strengthen political commitment, increase sustainable funding and expand access to preventive interventions, rapid diagnostic services and effective treatment.

It also urged increased investment in research and the development of new vaccines, diagnostic technologies and treatment options, stressing that accelerated global action remained essential to ending the tuberculosis epidemic.

Advertisement
Advertisement

Leave a Reply

Your email address will not be published. Required fields are marked *